Patents by Inventor Malgorzata Agnieszka NOCULA-LUGOWSKA

Malgorzata Agnieszka NOCULA-LUGOWSKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ROR ANTIBODY CONSTRUCTS
    Publication number: 20240392002
    Abstract: Anti-ROR antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: August 12, 2024
    Publication date: November 28, 2024
    Applicant: EXELIXIS, INC.
    Inventors: Lucas BAILEY, Qufei LI, Malgorzata Agnieszka NOCULA-LUGOWSKA, Bryan GLASER
  • Anti-ROR antibody constructs
    Patent number: 12084496
    Abstract: Anti-ROR antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: September 10, 2024
    Assignee: EXELIXIS, INC.
    Inventors: Lucas Bailey, Qufei Li, Malgorzata Agnieszka Nocula-Lugowska, Bryan Glaser
  • THERAPEUTIC ANTIBODIES AND THEIR USES
    Publication number: 20240018244
    Abstract: The present invention relates to antibodies that specifically bind to B7-H4 (B7 Homology 4, encoded by gene VTCN1) and bispecific antibodies that specifically bind to both B7-H4 and CD3 (Cluster of Differentiation 3), and polynucleotides, pharmaceutical compositions and methods and uses thereof.
    Type: Application
    Filed: August 15, 2023
    Publication date: January 18, 2024
    Applicant: Pfizer Inc.
    Inventors: James Reasoner Apgar, Andrea Therese Hooper, Malgorzata Agnieszka Nocula-Lugowska, Lei Wu
  • Therapeutic antibodies and their uses
    Patent number: 11840572
    Abstract: The present invention relates to antibodies that specifically bind to B7-H4 (B7 Homology 4, encoded by gene VTCN1) and bispecific antibodies that specifically bind to both B7-H4 and CD3 (Cluster of Differentiation 3), and polynucleotides, pharmaceutical compositions and methods and uses thereof.
    Type: Grant
    Filed: July 16, 2021
    Date of Patent: December 12, 2023
    Assignee: Pfizer Inc.
    Inventors: James Reasoner Apgar, Andrea Therese Hooper, Malgorzata Agnieszka Nocula-Lugowska, Lei Wu
  • THERAPEUTIC ANTIBODIES AND THEIR USES
    Publication number: 20220017622
    Abstract: The present invention relates to antibodies that specifically bind to B7-H4 (B7 Homology 4, encoded by gene VTCN1) and bispecific antibodies that specifically bind to both B7-H4 and CD3 (Cluster of Differentiation 3), and polynucleotides, pharmaceutical compositions and methods and uses thereof.
    Type: Application
    Filed: July 16, 2021
    Publication date: January 20, 2022
    Applicant: PFIZER INC.
    Inventors: JAMES REASONER APGAR, ANDREA THERESE HOOPER, MALGORZATA AGNIESZKA NOCULA-LUGOWSKA, LEI WU
  • TRIVALENT TRISPECIFIC ANTIBODY CONSTRUCTS
    Publication number: 20210179734
    Abstract: Trispecific trivalent antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: April 17, 2019
    Publication date: June 17, 2021
    Inventors: Lucas BAILEY, Bryan GLASER, Qufei LI, Roland GREEN, Dileep Kumar PULUKKUNAT, Malgorzata Agnieszka NOCULA-LUGOWSKA, Daniel Justin GERHARDT
  • BINDING MOLECULES
    Publication number: 20210163594
    Abstract: Binding molecules, constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: April 17, 2019
    Publication date: June 3, 2021
    Inventors: Lucas BAILEY, Bryan GLASER, Qufei LI, Roland GREEN, Dileep Kumar PULUKKUNAT, Malgorzata Agnieszka NOCULA-LUGOWSKA, Daniel Justin GERHARDT, Matthew Joseph BISSEN
  • ANTI-ROR ANTIBODY CONSTRUCTS
    Publication number: 20210155692
    Abstract: Anti-ROR antibody constructs, pharmaceutical compositions comprising the constructs, and methods of use thereof are presented.
    Type: Application
    Filed: April 18, 2019
    Publication date: May 27, 2021
    Applicant: EXELIXIS, INC.
    Inventors: Lucas BAILEY, Qufei LI, Malgorzata Agnieszka NOCULA-LUGOWSKA, Bryan GLASER